← Back to headlines
Aspen Pharmaceuticals Increases Dividend Payout Driven by GLP-1 Drug Demand
The South African pharmaceutical company raised shareholder returns as sales of Mounjaro and similar weight-loss medications surge, positioning itself at a critical growth inflection point.
2 Sept, 13:36 — 2 Sept, 13:36
Sources
Showing 1 of 1 sources
Related Stories
Revolut Secures Conditional U.S. National Bank Charter
25m ago
Ryanair Cuts Winter Flight Capacity and Warns of Fare Increases Amid High Fuel Costs
33m ago
Canada’s Trade Surplus Narrows in July Amid Falling Exports
39m ago
Snowflake Stock Soars After AI-Driven Revenue Growth Powers Blowout Quarter
51m ago